Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | CCR1 | P32246 | 3/20 | 0.48 |
| ▸ | CCR8 | P51685 | 3/20 | 0.48 |
| ▸ | CCR5 | P51681 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18647368 | 0.89 | MAPT (0.45) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL25671886 | 0.81 | LIMK1 (0.40) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL25461964 | 0.80 | ALDH1A1 (0.42) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL25672224 | 0.80 | NR4A2 (0.45) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL21030541 | 0.80 | CYP3A4 (0.44) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL21622648 | 0.80 | LMNA (0.44) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL21622848 | 0.80 | LMNA (0.44) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL21622847 | 0.80 | ALOX5 (0.49) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL25462076 | 0.79 | CCR1 (0.41) | LMNAMAPTKDM4ECCR1CCR8 | |
| SCHEMBL21622636 | 0.79 | LMNA (0.43) | LMNAMAPTKDM4ECCR1CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023282236-A1 | RARE EARTH COMPLEX | 東ソー株式会社 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | LMNA 674/4885MAPT 3174/4885KDM4E 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.